Skip to main content
PepStack
Blutwerte · Marker

Transferrin

Serum Transferrin · Siderophilin

Eisen & Anämie
Einheit:
g/L

Transferrin quantifies the level of iron-binding glycoprotein in the blood, reflecting iron transport capacity.

Reference Ranges

Reference
2–3.6g/L
2
3.6
LowNormalHigh
Reference
Unit · g/L

Ranges may vary slightly based on laboratory standards.

Overview

Übersicht

Transferrin is a glycoprotein primarily responsible for the transportation of iron throughout the bloodstream to various tissues. It binds iron ions and delivers them to cells via transferrin receptors, playing a crucial role in iron homeostasis. Researchers have observed that transferrin levels can provide insights into the body's iron status and are often evaluated alongside other markers such as ferritin and transferrin saturation. Clinically, transferrin levels are significant in diagnosing and managing conditions related to iron metabolism, including iron deficiency anemia and anemia of chronic disease. Elevated transferrin levels may indicate iron deficiency, as the body increases transferrin production to maximize iron transport. Conversely, low transferrin levels can be associated with conditions like chronic inflammation or liver disease. For athletes and biohackers, maintaining optimal transferrin levels is crucial for ensuring efficient oxygen transport and energy metabolism, which can impact performance and recovery. However, researchers have found that factors such as diet, inflammation, and liver function can confound transferrin measurements. Fasting is not required for testing, but it is recommended to consider potential interfering factors such as recent iron supplementation or acute illness.

Klinische Bedeutung

Elevated transferrin levels often indicate iron deficiency, as the body increases transferrin production to enhance iron transport. Reduced transferrin levels may suggest chronic inflammation, liver disease, or malnutrition.

Dynamics

Trend Interpretation

Rising Values

Progressively rising transferrin levels suggest worsening iron deficiency. Re-test in 4 weeks if outside optimal range.

Falling Values

Falling transferrin levels may indicate improving iron status or the onset of chronic disease.

Re-test Interval

4 weeks if outside optimal range

Etiology

Causes — High & Low

Cause

Elevated Levels

  • Iron deficiency
  • Pregnancy
  • Oral contraceptive use
  • Estrogen therapy
  • Chronic blood loss
Cause

Low Levels

  • Chronic inflammation
  • Liver disease
  • Malnutrition
  • Nephrotic syndrome
  • Hemochromatosis
Protocol

How to Optimize

Lever

Lifestyle

  • Regular physical activity
  • Stress management
  • Adequate sleep
Lever

Nutrition

  • Iron-rich foods
  • Vitamin C-rich foods
  • Avoid excessive tea/coffee with meals
Lever

Supplementation

  • Iron supplements
  • Vitamin C
  • Multivitamins with iron

Note:

Consult a physician before starting iron supplementation, especially if underlying conditions are suspected.

Testing Guidelines

✓Fasting Not Required
✓Not Time-Sensitive

Transferrin levels can vary throughout the day; consistent timing for tests is recommended.

Testing Frequency

Annually for healthy adults; more frequently if managing iron-related conditions.

Interfering Factors

  • Recent iron supplementation
  • Acute illness
  • Hormonal contraceptives

Related Peptides & Hormones

Hepcidin

Correlated with

hormone

Open Research Questions

Current research suggests that the reference ranges for transferrin and its receptor, particularly in diverse populations and clinical contexts, remain debated, with optimal targets for diagnosis and management of iron deficiency anemia still not established. Emerging research directions include the exploration of transferrin receptor ratios in differentiating types of anemia and the role of transferrin in ferroptosis. Unanswered clinical questions include the impact of physiological factors on transferrin levels and the effectiveness of novel biomarkers in routine diagnostics.

46 Research Publications

1,892

Total Citations

14

Human/RCT

4.2

Avg. Influence

2024

Latest

Sort
Filter
#01

Transferrin Receptor Is a Specific Ferroptosis Marker.

AnimalInfluence22.0
788
This study identified the transferrin receptor as a specific marker for ferroptosis, a regulated cell death process. Researchers developed a monoclonal antibody that effectively detects cells undergoing ferroptosis by targeting the human transferrin receptor 1 protein. This finding may enhance the understanding of ferroptosis in various biological contexts.
View on PubMed
#02

Laboratory markers of alcohol abuse.

ReviewInfluence6.0
156
This study explored laboratory markers for alcohol abuse, highlighting serum carbohydrate-deficient transferrin (CDT) as a promising marker. Researchers found that CDT has greater potential than existing tests for detecting alcohol abuse, especially when used in combination with other markers.
View on PubMed
#03

Transferrin-binding proteins isolated from Neisseria meningitidis elicit protective and bactericidal antibodies in laboratory animals.

AnimalInfluence2.0
133
This study focused on transferrin-binding proteins from Neisseria meningitidis and their ability to elicit protective antibodies in mice. Researchers found that immunization with these proteins significantly increased survival rates against bacterial challenges.
View on PubMed
#04

Transferrin Saturation: A Body Iron Biomarker.

ReviewInfluence8.0
124
Researchers examined transferrin saturation (TSAT) as a biomarker for body iron status. They found that TSAT is important for detecting iron deficiency and overload, but caution is needed during interpretation, especially in inflammatory conditions. The study also linked TSAT levels to cardiovascular mortality, suggesting potential for risk assessment.
View on PubMed
#05

The challenge of CDG diagnosis.

ReviewInfluence2.0
101
Researchers discussed the challenges in diagnosing congenital disorders of glycosylation (CDG) and noted that serum transferrin isoelectrofocusing is only positive in about 60% of cases. They provided practical tools to aid in CDG diagnosis, emphasizing the importance of recognizing clinical features suggestive of these disorders.
View on PubMed
#06

The measurement of serum transferrin receptor.

ReviewInfluence2.0
83
Researchers observed that serum transferrin receptor levels are a useful indicator of iron deficiency and erythropoiesis. They highlighted its clinical utility in distinguishing between different types of anemia, particularly in identifying iron deficiency anemia. The study supports the routine use of this marker in evaluating anemic patients.
View on PubMed
#07

Diagnosing iron deficiency: Controversies and novel metrics.

ReviewInfluence4.0
71
This review examined various established and novel biomarkers for diagnosing iron deficiency, including transferrin and ferritin. Researchers found that understanding these markers can improve patient care and guide future research in iron metabolism. The review highlights the complexities and controversies surrounding the diagnostic criteria for different types of anemia.
View on PubMed
#08

Oral D-galactose supplementation in PGM1-CDG.

HumanInfluence4.0
69
This pilot study evaluated the effects of oral D-galactose supplementation in patients with phosphoglucomutase-1 deficiency. Researchers found significant improvements in transferrin glycosylation and other biomarkers, suggesting its potential benefits.
View on PubMed
#09

Transferrin receptor in tissue and serum: updated clinical significance of soluble receptor.

ReviewInfluence1.0
54
This study focused on the clinical significance of transferrin receptors in iron metabolism. Researchers found that measuring serum transferrin receptor levels can differentiate between iron deficiency anemia and other types of anemia. They highlighted the importance of transferrin receptor-ferritin ratios in assessing iron status.
View on PubMed
#10

Standardisation and use of the alcohol biomarker carbohydrate-deficient transferrin (CDT).

ReviewInfluence1.0
52
Researchers summarized efforts to standardize the measurement of carbohydrate-deficient transferrin (CDT), an alcohol biomarker. They highlighted the establishment of reference laboratories and procedures to improve the consistency of CDT test results.
View on PubMed

Clinical Trials (8)

8

Total Trials

1,576

Total Enrolled

Intensive Care Outcome Prediction Using Admission Carbohydrate-deficient Transferrin

NCT07632716RECRUITING
Sponsor

Medical University of Vienna

Enrollment

800

Started

2026

Primary outcome

The primary outcome of the study is 30-day all-cause mortality in ICU patients.

Intensive Care (ICU)Critical IllnessAlcohol Misuse

T2 Star Magnetic Resonance Imaging and Biomarker Blood Testing to Predict the Change and Progress of Malignant Gliomas

NCT07447531RECRUITING
Sponsor

John M. Buatti

Enrollment

15

Started

2025

Primary outcome

Relationship between T2 (observed)-weighted imaging (T2*) magnetic resonance imaging relation time and dimeric transferrin receptor expression

Malignant Glioma

Evaluation of the Effect of Artesunate in Friedreich Ataxia (FA)

NCT04921930Phase 1/2COMPLETED
Sponsor

Institut National de la Santé Et de la Recherche Médicale, France

Enrollment

20

Started

2022

Primary outcome

Search for the maximal tolerated and effective dose of oral artesunate to regulate iron homeostasis and Transferrin 1 receptor (TfR1) immunofluorescence in Peripheral Blood Mononuclear Cells (PBMCs)

Friedreich Ataxia

Impact of Transferrin Saturation Guided Maintenance Treatment on Quality of Life in HFE Haemochromatosis

NCT04779593ACTIVE_NOT_RECRUITING
Sponsor

Rennes University Hospital

Enrollment

239

Started

2021

Primary outcome

The primary evaluation criteria is the Physical Component Score of the SF-36 questionnaire at the end of the study period (two years)

Haemochromatosis

Transferrin Saturation and Asthenia in Hemochromatosis

NCT03356548COMPLETED
Sponsor

Rennes University Hospital

Enrollment

260

Started

2017

Primary outcome

Quality of life questionnaire SF 36

Hemochromatoses, Genetic

Genes-in-Action - Hepcidin Regulation of Iron Supplementation

NCT03341338COMPLETED
Sponsor

London School of Hygiene and Tropical Medicine

Enrollment

206

Started

2016

Primary outcome

transferrin saturation (TSAT)

Anemia

Cerebrospinal Fluid Rhinorrhea After Functional Endoscopic Sinus Surgery

NCT02382692COMPLETED
Sponsor

University of Zurich

Enrollment

31

Started

2015

Primary outcome

Beta-2-Transferrin positive or negative

Cerebrospinal Fluid Leakage

Apotransferrin in Atransferrinemia

NCT01797055Phase 2ACTIVE_NOT_RECRUITING
Sponsor

Prothya Biosolutions

Enrollment

5

Started

2010

Primary outcome

Hemoglobin

Congenital Atransferrinemia

Publication Trend

Research publications about Transferrin over time

9total
1
'94
1
'96
1
'01
1
'02
1
'16
1
'19
1
'20
1
'23
1
'25

Track your bloodwork in PepStack

Log lab results, track trends and optimize your biomarkers over time.

Legal Disclaimer

This page is for informational and research purposes only. All information is based on published scientific literature and does not constitute medical advice, diagnosis, or treatment recommendations. Many substances listed may not be approved for human use and may be subject to drug regulation laws (e.g., AMG in Germany, FDA in the US). PepStack does not encourage the use of any substance on humans. Always consult a qualified healthcare professional before making any health-related decisions. Use of this information is entirely at your own risk. PepStack assumes no liability for the accuracy, completeness, or timeliness of the content provided. Full disclaimer